par Tassignon, J;Vandevelde, M;Goldman, Michel 
Référence Clinical immunology, 100, 1, page (24-30)
Publication Publié, 2001-07
Référence Clinical immunology, 100, 1, page (24-30)
Publication Publié, 2001-07
Article révisé par les pairs
| Titre: |
|
| Auteur: | Tassignon, J; Vandevelde, M; Goldman, Michel |
| Informations sur la publication: | Clinical immunology, 100, 1, page (24-30) |
| Statut de publication: | Publié, 2001-07 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Calcium mobilization machinery |
| Combination index | |
| Cyclosporine A | |
| Flow cytometry | |
| Immunosuppression | |
| Isoboles | |
| Median effect | |
| Semiquantitative PCR | |
| MeSH keywords: | Adult |
| Antigens, CD -- biosynthesis | |
| Antigens, CD -- genetics | |
| Antigens, Differentiation, T-Lymphocyte -- biosynthesis | |
| Antigens, Differentiation, T-Lymphocyte -- genetics | |
| Azo Compounds -- pharmacology | |
| CD4-Positive T-Lymphocytes -- drug effects | |
| CD4-Positive T-Lymphocytes -- immunology | |
| Calcimycin -- pharmacology | |
| Calcineurin -- antagonists & inhibitors | |
| Calcium Signaling -- drug effects | |
| Cells, Cultured | |
| Cyclosporine -- pharmacology | |
| DNA-Binding Proteins -- metabolism | |
| Down-Regulation -- drug effects | |
| Drug Synergism | |
| G1 Phase -- drug effects | |
| Gene Expression Regulation -- drug effects | |
| Humans | |
| Immunosuppressive Agents -- pharmacology | |
| Interleukin-2 -- biosynthesis | |
| Interleukin-2 -- genetics | |
| Ionophores -- pharmacology | |
| Lymphocyte Activation -- drug effects | |
| NFATC Transcription Factors | |
| Nuclear Proteins | |
| Receptors, Interleukin-2 -- biosynthesis | |
| Receptors, Interleukin-2 -- genetics | |
| Transcription Factors -- metabolism | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1521-6616 |
| info:doi/10.1006/clim.2001.5041 | |
| info:pii/S1521-6616(01)95041-7 | |
| info:scp/0034972460 | |
| info:pmid/11414742 |
